March 30, 2023 — GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain, and the United Kingdom, will launch ViewRay’s advanced MRIdian MRI-guided radiation therapy system at the Lee Health

March 29, 2023 — A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), commonly known as chemo-brain. Armed with this information, patients can understand better the changes in their cognitive status during and after treatment.

March 29, 2023 — Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the monitoring and treatment of cancers, today announced the licensing of a Granzyme B-targeted agent for PET imaging applications from Merck, known as MSD outside the United States and Canada.

March 29, 2023 — Over 2,000 leading executives have committed to attend 

March 29, 2023 — In a partnership which aims to provide faster and safer medical imaging across Australia and New Zealand, Getz Healthcare announced that it has partnered with Subtle Medical, a Menlo Park, CA-based healthcare technology company, to distribute the company's artificial intelligence (AI)-based software solutions for faster and safer medical imaging.

Many healthcare organizations are turning to the public cloud to be more flexible, agile and scalable when deploying and managing their software. Because no upfront investment is required, the cloud offers a cost-effective option that allows organizations to pay as they go without having to purchase additional hardware or technology.

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart disease during their lifetime, according to a new study published by an international consortium of researchers.

March 28, 2023 — A new article in The Journal of Nuclear Medicine explores the potential for using ChatGPT, an artificial intelligence chatbot, in the field of nuclear medicine and molecular imaging.

March 28, 2023 — Researchers found that a minimally invasive procedure combined with epidural steroid injection treatment led to superior pain reduction and disability improvement over one year in patients with sciatica.

March 27, 2023 — On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging (IMI) agents to target and illuminate cancer during surgery,  announced publication of results from the ELUCIDATE Phase 3 Trial of CYTALUX (pafolacianine) injection for use of IMI for

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now